Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend By: MarketWatch February 01, 2023 at 01:39 AM EST The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment in Roche Holding. Read More >> Related Stocks: Novartis Ag ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend By: MarketWatch February 01, 2023 at 01:39 AM EST The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment in Roche Holding. Read More >> Related Stocks: Novartis Ag ADR